Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 3Phase 3 1Phase 1 1

Status

Active not recruiting 5Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 6OTHER 1NETWORK 1

Study Type

Interventional 8

Sponsor

Cancer Type

Thoracic 8Gastrointestinal 3CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 3Colorectal Neoplasms 3Small Cell Lung Carcinoma 1Neoplasm Metastasis 1NSCLC 1Brain Neoplasms 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
JDQ443 × Thoracic × Clear all
NCT05132075 2026-06-02

KontRASt-02

Novartis

Phase 3 Active not recruiting
95 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05445843 2026-05-14

KontRASt-06

Novartis

Phase 2 Active not recruiting
95 enrolled 20 charts
Thoracic

Lung Neoplasms

NCT05358249 2026-04-14

KontRASt-03

Novartis

Phase 1/2 Active not recruiting
74 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07468071 2026-04-02

KontRASt-R

Novartis

Phase 1/2 Not yet recruiting
40 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT04699188 2026-03-18

KontRASt-01

Novartis

Phase 1/2 Active not recruiting
344 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT05714891 2026-02-12

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

Canadian Cancer Trials Group

Phase 2 Active not recruiting
4 enrolled
Thoracic

NSCLC

NCT05329623 2025-10-10

A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.

Novartis

Phase 1 Completed
33 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05999357 2024-05-29

STRIDER

Maastricht University Medical Center

Phase 2 Withdrawn
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡